0.2 ML lanreotide 300 MG/ML Prefilled Syringe [Somatuline]0.3 ML lanreotide 300 MG/ML Prefilled Syringe [Somatuline]
View 1 more
NO BLACK BOX WARNING
Dosage & administration
Administration :
Recommended Dosage
* Acromegaly: 90 mg every 4 weeks for 3 months. Adjust thereafter based on GH and/or IGF-1 levels. See full prescribing information for titration regimen. * GEP-NETs: 120 mg every 4 weeks. * Carcinoid Syndrome: 120 mg every 4 weeks. If patients are already being treated with SOMATULINE DEPOT for GEP-NET, do not administer an additional dose for carcinoid syndrome.
Dosage Adjustment:
* See full prescribing information for dosage adjustment in patients with acromegaly and renal or hepatic impairment.
biomarker testing
Somatuline clinical details
Genetic testing requirements were obtained from the NCCN guidelines for each cancer type.
Benefits investigations are conducted to determine whether a therapy is covered under a patient's insurance, if a prior authorization is required, and which specialty pharmacies are preferred.
Some brands offer a field reimbursement manager who will work with your clinical staff and preferred pharmacy to help make sure patients don't fall through the cracks.
Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)
Patient benefit
A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max
Patient eligibility
Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance
How to sign up
Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form
Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned
Patient benefit
Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted
Patient eligibility
Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.
How to sign up
Patients submit proof of out-of-pocket drug costs to charities for reimbursement
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Learn More
Other resources brands publish to help support patients.
people also ask
Somatuline FAQs
How is the dosage of Somatuline?Somatuline is available in 3 dosages, including 240 mg/ml Prefilled Syringe 0.5 ml, 300 mg/ml Prefilled Syringe 0.2 ml and 300 mg/ml Prefilled Syringe 0.3 ml
What does Somatuline treat?Somatuline treats Acromegaly and Neuroendocrine Tumors
What is Somatuline made of?Somatuline contains lanreotide which is a Somatostatin Analog
How Is Somatuline Administered?Somatuline is administered as a Injectable
What Are The Somatuline Mechanism Of Action?Somatuline mechanism of action is Somatostatin Receptor Agonists
FAQ Data Source
We receive information directly from the FDA and PrescriberPoint is updated as frequently as change are made available